A Study of Zevalin and Simultaneous Application of BEAM High-dose Chemotherapy Followed by Autologous Stem Cell Transplantation in Refractory and Relapsed Aggressive Non-Hodgkin Lymphomas

Clinical trial NCT00521560 · COMPLETED

Trial details

NCT number: NCT00521560
Sponsor: Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Non-Hodgkin-Lymphoma Refractory Non-Hodgkin-Lymphoma CD20+ Aggressive Non-Hodgkin's Lymphoma

Start date: 2006-03-01
Primary completion: 2009-08-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.